Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations
Identifieur interne : 001561 ( Main/Exploration ); précédent : 001560; suivant : 001562Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations
Auteurs : Th. Mertens ; Gabriele Tondorf ; M. Siebolds ; J. P. Kruppenbacher ; H. J. Eggers ; S. M. Shrestha [Népal] ; G. Mauff ; L. GürtlerSource :
- Infection [ 0300-8126 ] ; 1989-01-01.
Descripteurs français
English descriptors
- KwdEn :
- African sera, Definite diagnosis, Elisa, Epidemiological situation, Hepatitis, High prevalence, Human immunodeficiency virus, Katmandu, Katmandu patients, Liver diseases, Nepal, Positive sera, Prevalence, Rural hospital, Screening test, Sociodemographic data, Stringent criteria, Study population, Uninfected cells, Viral hepatitis, Western blots, Zimbabwe, Zimbabwe study population.
- Teeft :
- African sera, Definite diagnosis, Elisa, Epidemiological situation, Hepatitis, High prevalence, Human immunodeficiency virus, Katmandu, Katmandu patients, Liver diseases, Nepal, Positive sera, Prevalence, Rural hospital, Screening test, Sociodemographic data, Stringent criteria, Study population, Uninfected cells, Viral hepatitis, Western blots, Zimbabwe, Zimbabwe study population.
Abstract
Summary: 401 sera from patients of a rural hospital in Zimbabwe (1987), 211 South African sera (1982/83), as well as 460 sera from four Katmandu hospitals (1985) were tested for HIV-1 antibodies. The sera from Zimbabwe and Nepal were additionally tested for anti-HIV-2 using a panel of different tests, for hepatitis B markers, and partially for antibodies against other viral, bacterial, and protozoal antigens. Detailed clinical and sociodemographic data were taken from the Zimbabwe and Katmandu patients. The prevalence of HIV-1 antibodies in the Zimbabwe study population was 3.2%. All infections were found in the age group 17 to 30 years (n=254). The epidemiological situation was entirely different from that of HBV (hepatitis B virus). No serum could be confirmed to be anti-HIV-2-positive, but a definite diagnosis is still difficult to establish. Regular town contacts may be considered a possible risk factor. Antibodies against HIV-1 could not be detected in the South African and Asian sera. The seropositivity for anti-HBc in Katmandu (14%) and the prevalence of HBsAg (1.1%) was much lower than reported from other Asian countries.
Url:
DOI: 10.1007/BF01643488
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000026
- to stream Istex, to step Curation: 000026
- to stream Istex, to step Checkpoint: 000965
- to stream Main, to step Merge: 001695
- to stream Main, to step Curation: 001561
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations</title><author><name sortKey="Mertens, Th" sort="Mertens, Th" uniqKey="Mertens T" first="Th." last="Mertens">Th. Mertens</name></author><author><name sortKey="Tondorf, Gabriele" sort="Tondorf, Gabriele" uniqKey="Tondorf G" first="Gabriele" last="Tondorf">Gabriele Tondorf</name></author><author><name sortKey="Siebolds, M" sort="Siebolds, M" uniqKey="Siebolds M" first="M." last="Siebolds">M. Siebolds</name></author><author><name sortKey="Kruppenbacher, J P" sort="Kruppenbacher, J P" uniqKey="Kruppenbacher J" first="J. P." last="Kruppenbacher">J. P. Kruppenbacher</name></author><author><name sortKey="Eggers, H J" sort="Eggers, H J" uniqKey="Eggers H" first="H. J." last="Eggers">H. J. Eggers</name></author><author><name sortKey="Shrestha, S M" sort="Shrestha, S M" uniqKey="Shrestha S" first="S. M." last="Shrestha">S. M. Shrestha</name></author><author><name sortKey="Mauff, G" sort="Mauff, G" uniqKey="Mauff G" first="G." last="Mauff">G. Mauff</name></author><author><name sortKey="Gurtler, L" sort="Gurtler, L" uniqKey="Gurtler L" first="L." last="Gürtler">L. Gürtler</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0FF91359173FF6C87ECEED8E39A73A67E181DFF8</idno><date when="1989" year="1989">1989</date><idno type="doi">10.1007/BF01643488</idno><idno type="url">https://api.istex.fr/document/0FF91359173FF6C87ECEED8E39A73A67E181DFF8/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000026</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000026</idno><idno type="wicri:Area/Istex/Curation">000026</idno><idno type="wicri:Area/Istex/Checkpoint">000965</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000965</idno><idno type="wicri:doubleKey">0300-8126:1989:Mertens T:epidemiology:of:hiv</idno><idno type="wicri:Area/Main/Merge">001695</idno><idno type="wicri:Area/Main/Curation">001561</idno><idno type="wicri:Area/Main/Exploration">001561</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations</title><author><name sortKey="Mertens, Th" sort="Mertens, Th" uniqKey="Mertens T" first="Th." last="Mertens">Th. Mertens</name><affiliation><wicri:noCountry code="subField">41</wicri:noCountry></affiliation></author><author><name sortKey="Tondorf, Gabriele" sort="Tondorf, Gabriele" uniqKey="Tondorf G" first="Gabriele" last="Tondorf">Gabriele Tondorf</name><affiliation><wicri:noCountry code="subField">41</wicri:noCountry></affiliation></author><author><name sortKey="Siebolds, M" sort="Siebolds, M" uniqKey="Siebolds M" first="M." last="Siebolds">M. Siebolds</name><affiliation><wicri:noCountry code="subField">41</wicri:noCountry></affiliation></author><author><name sortKey="Kruppenbacher, J P" sort="Kruppenbacher, J P" uniqKey="Kruppenbacher J" first="J. P." last="Kruppenbacher">J. P. Kruppenbacher</name><affiliation><wicri:noCountry code="subField">41</wicri:noCountry></affiliation></author><author><name sortKey="Eggers, H J" sort="Eggers, H J" uniqKey="Eggers H" first="H. J." last="Eggers">H. J. Eggers</name><affiliation><wicri:noCountry code="subField">41</wicri:noCountry></affiliation></author><author><name sortKey="Shrestha, S M" sort="Shrestha, S M" uniqKey="Shrestha S" first="S. M." last="Shrestha">S. M. Shrestha</name><affiliation wicri:level="1"><country xml:lang="fr">Népal</country><wicri:regionArea>Bir-Hospital, P.O. Box 3439, Katmandu</wicri:regionArea><wicri:noRegion>Katmandu</wicri:noRegion></affiliation></author><author><name sortKey="Mauff, G" sort="Mauff, G" uniqKey="Mauff G" first="G." last="Mauff">G. Mauff</name><affiliation><wicri:noCountry code="subField">41</wicri:noCountry></affiliation></author><author><name sortKey="Gurtler, L" sort="Gurtler, L" uniqKey="Gurtler L" first="L." last="Gürtler">L. Gürtler</name><affiliation><wicri:noCountry code="subField">2</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j">Infection</title><title level="j" type="sub">A Journal of INFECTIOUS Disease</title><title level="j" type="abbrev">Infection</title><idno type="ISSN">0300-8126</idno><idno type="eISSN">1439-0973</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="1989-01-01">1989-01-01</date><biblScope unit="volume">17</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="4">4</biblScope><biblScope unit="page" to="7">7</biblScope></imprint><idno type="ISSN">0300-8126</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0300-8126</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>African sera</term><term>Definite diagnosis</term><term>Elisa</term><term>Epidemiological situation</term><term>Hepatitis</term><term>High prevalence</term><term>Human immunodeficiency virus</term><term>Katmandu</term><term>Katmandu patients</term><term>Liver diseases</term><term>Nepal</term><term>Positive sera</term><term>Prevalence</term><term>Rural hospital</term><term>Screening test</term><term>Sociodemographic data</term><term>Stringent criteria</term><term>Study population</term><term>Uninfected cells</term><term>Viral hepatitis</term><term>Western blots</term><term>Zimbabwe</term><term>Zimbabwe study population</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>African sera</term><term>Definite diagnosis</term><term>Elisa</term><term>Epidemiological situation</term><term>Hepatitis</term><term>High prevalence</term><term>Human immunodeficiency virus</term><term>Katmandu</term><term>Katmandu patients</term><term>Liver diseases</term><term>Nepal</term><term>Positive sera</term><term>Prevalence</term><term>Rural hospital</term><term>Screening test</term><term>Sociodemographic data</term><term>Stringent criteria</term><term>Study population</term><term>Uninfected cells</term><term>Viral hepatitis</term><term>Western blots</term><term>Zimbabwe</term><term>Zimbabwe study population</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Népal</term><term>Zimbabwe</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Summary: 401 sera from patients of a rural hospital in Zimbabwe (1987), 211 South African sera (1982/83), as well as 460 sera from four Katmandu hospitals (1985) were tested for HIV-1 antibodies. The sera from Zimbabwe and Nepal were additionally tested for anti-HIV-2 using a panel of different tests, for hepatitis B markers, and partially for antibodies against other viral, bacterial, and protozoal antigens. Detailed clinical and sociodemographic data were taken from the Zimbabwe and Katmandu patients. The prevalence of HIV-1 antibodies in the Zimbabwe study population was 3.2%. All infections were found in the age group 17 to 30 years (n=254). The epidemiological situation was entirely different from that of HBV (hepatitis B virus). No serum could be confirmed to be anti-HIV-2-positive, but a definite diagnosis is still difficult to establish. Regular town contacts may be considered a possible risk factor. Antibodies against HIV-1 could not be detected in the South African and Asian sera. The seropositivity for anti-HBc in Katmandu (14%) and the prevalence of HBsAg (1.1%) was much lower than reported from other Asian countries.</div></front></TEI><affiliations><list><country><li>Népal</li></country></list><tree><noCountry><name sortKey="Eggers, H J" sort="Eggers, H J" uniqKey="Eggers H" first="H. J." last="Eggers">H. J. Eggers</name><name sortKey="Gurtler, L" sort="Gurtler, L" uniqKey="Gurtler L" first="L." last="Gürtler">L. Gürtler</name><name sortKey="Kruppenbacher, J P" sort="Kruppenbacher, J P" uniqKey="Kruppenbacher J" first="J. P." last="Kruppenbacher">J. P. Kruppenbacher</name><name sortKey="Mauff, G" sort="Mauff, G" uniqKey="Mauff G" first="G." last="Mauff">G. Mauff</name><name sortKey="Mertens, Th" sort="Mertens, Th" uniqKey="Mertens T" first="Th." last="Mertens">Th. Mertens</name><name sortKey="Siebolds, M" sort="Siebolds, M" uniqKey="Siebolds M" first="M." last="Siebolds">M. Siebolds</name><name sortKey="Tondorf, Gabriele" sort="Tondorf, Gabriele" uniqKey="Tondorf G" first="Gabriele" last="Tondorf">Gabriele Tondorf</name></noCountry><country name="Népal"><noRegion><name sortKey="Shrestha, S M" sort="Shrestha, S M" uniqKey="Shrestha S" first="S. M." last="Shrestha">S. M. Shrestha</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001561 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001561 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:0FF91359173FF6C87ECEED8E39A73A67E181DFF8
|texte= Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations
}}
| This area was generated with Dilib version V0.6.31. |  |